This course will prepare learners to effectively and safely manage the treatment of clients receiving methadone or buprenorphine for opioid use disorder. The course will also promote interprofessional collaboration among the health care team involved in the delivery of opioid dependence treatment.
This course has the same learning objectives as the ODT Core Course. Unlike the core course, this online version has no face-to face component.
Pharmacists who complete this course will be in compliance with the Ontario College of Pharmacists' policy regarding required training.
Explain the pharmacology of opioids and how they affect the brain
Assess patients for opioid dependence based on criteria in the Diagnostic and Statistical Manual of Mental Disorders (DSM)
Differentiate abstinence-based treatment and withdrawal management from methadone and buprenorphine maintenance treatment
Decide on the appropriate treatment modalities for opioid-dependent clients
Implement safe prescribing dosing and dispensing of methadone and buprenorphine
Incorporate urine drug testing into opioid maintenance treatment program
Include counselling and case management in methadone and buprenorphine maintenance treatment
Demonstrate interprofessional collaboration when providing opioid dependence treatment with methadone and buprenorphine
Certification and Accreditation
College of Family Physicians of Canada – Mainpro+: This Group Learning program meets the certification criteria of the College of Family Physicians of Canada and has been certified by Continuing Professional Development, Faculty of Medicine, University of Toronto for up to 15.5 Mainpro+ credits.
Royal College of Physicians and Surgeons of Canada – Section 1: This event is an Accredited Group Learning Activity (Section 1) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada, approved by Continuing Professional Development, Faculty of Medicine, University of Toronto. You may claim a maximum of 15.5 hours (credits are automatically calculated).
The Canadian Council on Continuing Education in Pharmacy has accredited this program for 15.5 CEUs.